← ANALYST RATINGS · TIPRANKS
AbSci (ABSI): analyst forecast and price target
Analyst consensus
Strong Buy8 Buy1 Hold0 Sell
Ratings of 9 analysts in the last 3 months12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $14.62, the highest $20.00, the lowest $10.00. The average is +77.3% from the last price of $8.25.
Analyst ratings 17
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.00 → $8.50−5.6% | Hold | +3.0% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $9.00 → $8.50−5.6% | Hold | +3.0% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $9.00 → $8.50−5.6% | Hold | +3.0% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $9.00 → $8.50−5.6% | Hold | +3.0% | Reiterated | 17.10.26on TipRanks 05:06 | — | |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | $16.00 → $20.00+25.0% | Buy | +142.4% | Reiterated | 16.10.26on TipRanks 07:35 | −6.0% | ↗ |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $9.50 → $9.00−5.3% | Hold | +9.1% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| Brian Cheng★★★★★★★★★★#1122 · hits 55% · avg +14.0% | J.P. Morgan | $14.00 → $15.00+7.1% | Buy | +81.8% | Reiterated | 12.10.26on TipRanks 08:40 | −4.8%next day −5.9% | ↗ |
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $16.00 | Buy | +93.9% | Reiterated | 12.10.26on TipRanks 06:50 | −4.8%next day −5.9% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $12.00 → $9.50−20.8% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $11.50 → $9.50−17.4% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $11.50 → $9.50−17.4% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $11.50 → $9.50−17.4% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $12.00 → $9.50−20.8% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $11.50 → $9.50−17.4% | Hold | +15.2% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| Kambiz Yazdi★★★★★★★★★★#1181 · hits 67% · avg +24.8% | BTIG | $16.00 | Buy | +93.9% | Reiterated | 06.10.26on TipRanks 06:50 | −11.5%next day −10.0% · 5 days −11.3% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $8.50 → $12.00+41.2% | Hold | +45.5% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $8.50 → $11.50+35.3% | Hold | +39.4% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $8.50 → $11.50+35.3% | Hold | +39.4% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $8.50 → $11.50+35.3% | Hold | +39.4% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $8.50 → $12.00+41.2% | Hold | +45.5% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $8.50 → $11.50+35.3% | Hold | +39.4% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| Kambiz Yazdi★★★★★★★★★★#1181 · hits 67% · avg +24.8% | BTIG | $16.00 | Buy | +93.9% | Reiterated | 01.10.26on TipRanks Oct 2 06:16 | −0.4%next day +2.2% · 5 days −18.1% | ↗ |
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $16.00 | Buy | +93.9% | Reiterated | 01.10.26on TipRanks 10:35 | −0.4%next day +2.2% · 5 days −18.1% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | — | Buy | — | Reiterated | 30.09.26on TipRanks Oct 1 02:35 | +6.4%next day −0.4% · 5 days −16.3% | ↗ |
| Rami Katkhuda★★★★★★★★★★#297 · hits 55% · avg +31.7% | LifeSci Capital | $16.00 | Buy | +93.9% | Reiterated | 24.09.26on TipRanks 10:45 | +6.2%next day −6.4% · 5 days +4.3% | ↗ |
| Gil Blum★★★★★★★★★★#949 · hits 43% · avg +12.5% | Needham | $11.00 | Buy | +33.3% | Reiterated | 23.09.26on TipRanks 07:55 | −8.3%next day +6.2% · 5 days +11.2% | ↗ |
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $16.00 | Buy | +93.9% | Reiterated | 21.09.26on TipRanks 13:55 | +0.2%next day +9.1% · 5 days −2.3% | ↗ |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $8.50 | Hold | +3.0% | Reiterated | 17.09.26on TipRanks 06:06 | — | |
| Kambiz Yazdi★★★★★★★★★★#1181 · hits 67% · avg +24.8% | BTIG | $13.00 → $16.00+23.1% | Buy | +93.9% | Assigned | 08.09.26on TipRanks 07:15 | +1.6%next day −2.5% · 5 days −9.8% | ↗ |
| Sean Laaman★★★★★★★★★★#446 · hits 67% · avg +17.2% | Morgan Stanley | $10.00 | Hold | +21.2% | Assigned | 17.08.26on TipRanks 08:55 | +1.1%next day −3.5% · 5 days −3.1% | ↗ |
| Debanjana Chatterjee★★★★★★★★★★#121 · hits 68% · avg +45.6% | JonesTrading | $13.00 | Buy | +57.6% | Reiterated | 12.08.26on TipRanks 16:25 | −1.1%next day −2.8% · 5 days +0.1% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | — | Buy | — | Reiterated | 11.08.26on TipRanks Aug 12 01:25 | +4.8%next day +0.7% · 5 days −5.5% | ↗ |
| Srikripa Devarakonda★★★★★★★★★★#200 · hits 62% · avg +26.3% | Truist Financial | $11.00 → $17.00+54.5% | Buy | +106.1% | Reiterated | 02.07.26on TipRanks 07:43 | +4.7%next day −1.6% · 5 days −10.1% | ↗ |
| Vamil Divan★★★★★★★★★★#458 · hits 59% · avg +13.5% | Guggenheim | $15.00 | Buy | +81.8% | Reiterated | 25.06.26on TipRanks 07:50 | +1.2%next day +7.4% · 5 days +12.4% | ↗ |
| Mani Foroohar★★★★★★★★★★#11266 · hits 43% · avg −2.1% | Leerink Partners | $12.00 | Buy | +45.5% | Initiated | 04.06.26on TipRanks 06:40 | +23.2%next day −10.2% · 5 days −8.8% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering AbSci
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $14.14 at a price of $10.77 (+31.3%); now: $14.62 at $8.25 (+77.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 10 | 8 | 6 | 7 | 10 |
| Buy | 6 | 10 | 12 | 12 | 9 | 8 |
| Hold | 2 | 3 | 3 | 3 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 12.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.19 (from $-0.22 to $-0.13). Last quarter: $-0.21.
Sales
Next quarter’s sales estimate — $1M (from $0M to $2M). Last quarter: $0M.
Best top-analyst consensus in the sector · Healthcare
About AbSci
- CEO: Sean McClain
- Employees: 140
- 18105 SE Mill Plain Boulevard, Vancouver, WA, 98683, US
- www.absci.com
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Data from the stock’s TipRanks forecast page, read 4 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗